Molecular culprits of protein aggregation in ALS and FTLD

July 19, 2018, VIB (the Flanders Institute for Biotechnology)

The mutated and aggregated protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers led by prof. Ludo Van Den Bosch (VIB-KU Leuven) have focused on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.

ALS and FTLD are adult-onset neurodegenerative disorders that differ in terms of the symptoms they cause and the neurons they affect. In ALS, the neurons that control muscle movement degenerate, resulting in progressive paralysis, while FTLD affects specific brain areas and causes dementia. Still, many patients present with symptoms of both diseases, so scientists and clinicians now believe they are actually on opposite ends of the same disease spectrum.

The overlap between ALS and FTLD is not only apparent in the clinic, but also when looking at the underlying disease mechanisms. FUS, for example, is implicated in both diseases. Mutations in the FUS gene cause familial ALS and aggregation of the FUS is observed in both ALS and FTLD.

From liquid droplets to insoluble aggregates

FUS normally resides in the nucleus of the cell, but relocates to stress granules in the cytoplasm upon cellular stress. Stress granules are basically in the cell, similar in content to the toxic protein aggregates found in ALS and FTLD, but different in that their assembly is dynamic and reversible.

Could these liquid serve as stepping stones toward the formation of aggregates that are typical for disease? "We believe so," says Elke Bogaert, one of the researchers working with prof. Van Den Bosch. "Both FUS droplets and hydrogels have been shown to undergo a switch to irreversible fibrillarization in a test tube, but this process has not been studied in a cellular context".

The team generated a fruit fly model of FUS toxicity to investigate the formation of liquid droplets in more detail. They identified a previously unrecognized synergistic effect between two different protein regions that mediate toxicity. "We found that the FUS protein that is misbehaving in ALS and FTLD can form liquid droplets via specific molecular interactions between hydrophobic and charged amino acids," explains Steven Boeynaems, another researcher involved in the study.One FUS protein domain was generally considered to mediate aggregation, but the new findings indicate that arginine residues in another region of the protein are also required for maturation of FUS in cellular stress granules.

Problems in flies, and humans?

Further experiments immediately hinted at the importance of this protein interaction. Boeynaems says, "We showed that the interactions between exactly these two protein domains could explain toxicity in our fruit fly ALS model, suggesting how the protein may be misregulated in patients as well."

Prof. Ludo Van Den Bosch underscores the importance of figuring out the exact process of this so-called phase separation of droplets, that mature into aggregates: "Deciphering how and why proteins such as FUS start aggregating in the brain will be key to understand neurodegenerative diseases and could lead to novel therapeutic strategies. Our new findings highlight an important role for arginine-rich domains in the pathology of these proteins."

Explore further: New toxic pathway identified for protein aggregates in neurodegenerative disease

More information: Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity, Bogaert, Boeynaems, et al. 2018 Cell Reports. www.cell.com/cell-reports/full … 2211-1247(18)30997-5

Related Stories

New toxic pathway identified for protein aggregates in neurodegenerative disease

March 17, 2017
Led by professor Ludo Van Den Bosch (VIB-KU Leuven), scientists from Belgium, the UK and the US have identified new processes that form protein "clumps" that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal ...

A new mechanism for neurodegeneration in a form of dementia

May 8, 2018
A new study in Biological Psychiatry reports that dementia-related and psychiatric-related proteins cluster together to form aggregates in the brain, leading to abnormal cell function and behavior. Aggregation of the protein ...

Researchers describe mechanism of protein accumulation in neurodegenerative diseases

April 20, 2018
Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have characterized the mechanism that initiates the pathological aggregation of the protein FUS, which plays a central role in two distinct neurodegenerative diseases.

Insights into familial middle-age dementia suggest new avenues for treatment

February 26, 2018
Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset dementia, and can lead to personality changes, impaired speaking and motor dysfunction. While most cases occur sporadically, several ...

Researchers find transport molecule has unexpected role

June 14, 2018
UT Southwestern researchers recently reported a basic science finding that might someday lead to better treatments for neurodegenerative diseases like a hereditary form of Lou Gehrig's disease.

Tau mutations may increase cancer risk

May 24, 2018
Mutations to the protein tau, commonly associated with neurodegenerative disorders, may serve as a novel risk factor for cancer, according to results published in Cancer Research, a journal of the American Association for ...

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

CRISPR technology targets mood-boosting receptors in brain

August 17, 2018
An estimated 13 percent of Americans take antidepressant drugs for depression, anxiety, chronic pain or sleep problems. For the 14 million Americans who have clinical depression, roughly one third don't find relief with antidepressants.

Brain response study upends thinking about why practice speeds up motor reaction times

August 16, 2018
Researchers in the Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine report that a computerized study of 36 healthy adult volunteers asked to repeat the same movement over and over became significantly ...

Newly identified role for inhibition in cerebellar plasticity and behavior

August 16, 2018
Almost everyone is familiar with the unique mixture of surprise and confusion that occurs after making a mistake during an everyday movement. It's a fairly startling experience—stumbling on a step or accidentally missing ...

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.